Against HSCT in Ph-positive ALL

(10:41)

Is HSCT for MS overrated? [Neurologist reviews data VS. Tysabri, Ocrevus, and Gilenya]

(16:47)

Can A Stem Cell Transplant Stop Your MS?

(8:25)

Latest updates on bloodless HSCT

(2:54)

Repositioning HSCT in the MS treatment algorithm

(2:13)

HSCT with Professor Richard Burt, MD

(58:22)

Suitability for Haematopoietic Stem Cell Transplantation (HSCT) for MS

(2:38)

The History of T-cell Depleted Haploidentical HSCT

(52:29)

Patient-reported outcomes in HSCT

(1:12)

Pathophysiology of HSCT-TMA

(4:14)

AHSCT vs. high-activity DMTs in MS treatment

(7:36)

Advances in the field of HSCT

(2:10)

Emotional impact – individual | Chris Wasey's vlog: HSCT for MS

(7:1econd)

The Power of Hematopoietic Stem Cell Transplant for Autoimmune Disorders with Dr. Richard Burt

(1:3:14)

abTCD haploidentical HSCT in pediatric AL: long-term outcomes

(2:26)

Impact of pre-treatment treatments | Chris Wasey's vlog: HSCT for MS

(3:14)

Late effects of HSCT in young patients with ALL: transition to adult services \u0026 long-term follow-up

(2:16)

Emerging treatment options for HSCT-TMA

(2:53)

Safety and efficacy of letermovir against cytomegalovirus in allogeneic stem cell transplant

(2:36)

What happens during Haematopoietic Stem Cell Transplantation (HSCT) for multiple sclerosis (MS)?

(2:29)